Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department
- PMID: 31111144
- DOI: 10.1093/ehjqcco/qcz019
Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department
Abstract
Aims: As assessment of patients with suspected acute coronary syndromes (ACS) in emergency departments (EDs) represents a major workload because high-sensitivity troponin (HsTn) T and I levels are frequently measured, and a minority of patients have final diagnosis of myocardial infarction (MI). We determined the relative frequencies of three patients groups: Type-I MI, Type-II MI (including acute myocardial injury).
Methods and results: Among 2738 consecutive patients with suspected ACS presenting to ED at Liverpool Hospital, Australia, between March and June 2014. We studied the use of invasive and pharmacological therapies, and 4-year outcomes. Adjudication of MI was according to the 4th universal definition as follows: (i) Type-I MI; (ii) Type-II MI (including acute myocardial injury), and (iii) chronic myocardial injury. Of 995 patients (36%) [median age 76 years (interquartile range 65-83)] with ≥2 HsTnT measurements and one >14 ng/L, 727 (73%) had chronic myocardial injury, 171 (17%) had Type-II MI, and 97 (9.7%) had Type-I MI; respective late mortality rates to 48 months were 33%, 43%, and 14% (P < 0.001). In-hospital angiography rates were 95% for patients with Type-I MI, [62% had percutaneous coronary intervention (PCI)] 24% (7% PCI) for those with Type-II MI, and 3.4% for chronic myocardial injury. On Cox modelling for mortality relative to Type 1 MI, adjusted hazard ratios were 1.94 [95% confidence intervals (CIs) 1.06-3.57]; P = 0.032 for Type 2 MI, and for chronic myocardial injury 1.14 (95% CIs 0.64-2.02); P = 0.66.
Conclusion: Among unselected patients undergoing HsTnT testing in EDs, Type-II MI including acute myocardial injury was more common than Type-I MI. Chronic myocardial injury, which occurred in three of four patients. Whereas patients with Type-II MI had higher late mortality than those with Type-I MI, after multivariable analyses mortality rates were marginally different.
Keywords: Chronic myocardial injury; HsTnT; Type-I MI; Type-II MI; mortality.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Comment in
-
High-sensitivity cardiac troponin: a double-edged sword.Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):3-4. doi: 10.1093/ehjqcco/qcz033. Eur Heart J Qual Care Clin Outcomes. 2020. PMID: 31263882 No abstract available.
Similar articles
-
Mortality at 5 Years Among Very Elderly Patients Undergoing High Sensitivity Troponin T Testing for Suspected Acute Coronary Syndromes.Heart Lung Circ. 2020 Nov;29(11):1696-1703. doi: 10.1016/j.hlc.2020.02.015. Epub 2020 Apr 14. Heart Lung Circ. 2020. PMID: 32439246
-
Prognostic Implications of High-Sensitivity Troponin T Levels Among Patients Attending Emergency Departments and Evaluated for an Acute Coronary Syndrome.Am J Med. 2021 Aug;134(8):1019-1028.e1. doi: 10.1016/j.amjmed.2021.03.005. Epub 2021 Apr 2. Am J Med. 2021. PMID: 33812862
-
Management and outcomes with 5-year mortality of patients with mildly elevated high-sensitivity troponin T levels not meeting criteria for myocardial infarction.Emerg Med Australas. 2024 Feb;36(1):62-70. doi: 10.1111/1742-6723.14298. Epub 2023 Sep 13. Emerg Med Australas. 2024. PMID: 37705175
-
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.J Am Coll Cardiol. 2013 Jul 16;62(3):242-251. doi: 10.1016/j.jacc.2013.04.043. Epub 2013 May 15. J Am Coll Cardiol. 2013. PMID: 23684676 Review.
-
Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention.Curr Opin Cardiol. 2022 Nov 1;37(6):488-494. doi: 10.1097/HCO.0000000000000995. Epub 2022 Sep 12. Curr Opin Cardiol. 2022. PMID: 36094520 Free PMC article. Review.
Cited by
-
COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies.Clinics (Sao Paulo). 2024 Aug 27;79:100473. doi: 10.1016/j.clinsp.2024.100473. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 39197405 Free PMC article.
-
Clinical characteristics and outcome of elderly patients admitted in emergency department with an oxygen mismatch and type 2 myocardial infarction or myocardial injury.Aging Clin Exp Res. 2022 Feb;34(2):429-437. doi: 10.1007/s40520-021-01932-w. Epub 2021 Jul 11. Aging Clin Exp Res. 2022. PMID: 34247343
-
RNA binding proteins in cardiovascular development and disease.Curr Top Dev Biol. 2024;156:51-119. doi: 10.1016/bs.ctdb.2024.01.007. Epub 2024 Mar 15. Curr Top Dev Biol. 2024. PMID: 38556427 Free PMC article.
-
Late Outcomes of Patients With Prehospital ST-Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation.J Am Heart Assoc. 2022 Jul 5;11(13):e025602. doi: 10.1161/JAHA.121.025602. Epub 2022 Jun 29. J Am Heart Assoc. 2022. PMID: 35766276 Free PMC article.
-
Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical Trial.JAMA Cardiol. 2022 Jul 1;7(7):690-698. doi: 10.1001/jamacardio.2022.1188. JAMA Cardiol. 2022. PMID: 35612860 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous